Faculty who have authored publication Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial.
Name | Title | Department | Institution |
---|---|---|---|
Ehab L. Atallah MD | Professor | Medicine | Medical College of Wisconsin |